BRIEF published on 04/30/2024 at 12:40, 1 year 10 months ago Ovation Science Launches Topicals with Planet 13 in Nevada Nevada Cannabis Market Planet 13 Invisicare Technology Ovation Science Cannabis Topicals
BRIEF published on 04/30/2024 at 12:40, 1 year 10 months ago Ovation Science lance des sujets avec Planet 13 au Nevada Marché Du Cannabis Au Nevada Planète 13 Technologie Invisicare Science De L'ovation Cannabis Topiques
BRIEF published on 04/30/2024 at 12:35, 1 year 10 months ago Immunic Highlights Extended Data from EMPhASIS Trial in Peer-Reviewed Journal Vidofludimus Calcium EMPhASIS Trial Relapsing-remitting Multiple Sclerosis Neuroprotection Immune Modulation
BRIEF published on 04/30/2024 at 12:35, 1 year 10 months ago Immunic présente des données étendues de l'essai EMPhASIS dans une revue à comité de lecture Vidofludimus Calcium Neuroprotection Essai EMPhASIS Sclérose En Plaques Rémittente Modulation Immunitaire
BRIEF published on 04/30/2024 at 12:35, 1 year 10 months ago IFabric Corp Achieves FDA Medical Device Registration for Innovative Apparel Medical Device Healthcare Innovation FDA Registration Apparel Technology Textile Technology
BRIEF published on 04/30/2024 at 12:35, 1 year 10 months ago IFabric Corp obtient l'enregistrement d'un dispositif médical par la FDA pour des vêtements innovants Innovation En Matière De Soins De Santé Dispositif Médical Enregistrement Auprès De La FDA Technologie Du Vêtement Technologie Textile
BRIEF published on 04/30/2024 at 12:35, 1 year 10 months ago Zomedica to Present Q1 2024 Financial Results and Business Update on May 9th Financial Results Conference Call Business Update Zomedica Q1 2024
BRIEF published on 04/30/2024 at 12:35, 1 year 10 months ago Zomedica présentera ses résultats financiers du premier trimestre 2024 et une mise à jour de ses activités le 9 mai Résultats Financiers Zomedica Conférence Téléphonique Mise À Jour De L'entreprise T1 2024
BRIEF published on 04/30/2024 at 12:35, 1 year 10 months ago NanoViricides Announces Successful Completion of Phase I Clinical Trial for NV-387 NanoViricides NV-387 Phase I Clinical Trial Antiviral Treatment RSV Infection
BRIEF published on 04/30/2024 at 12:35, 1 year 10 months ago NanoViricides annonce la réussite de l'essai clinique de phase I pour le NV-387 NanoViricides NV-387 Essai Clinique De Phase I Traitement Antiviral Infection Par Le VRS
Published on 03/11/2026 at 23:00, 1 hour ago Redwood AI Enhances Its Chemical Synthesis Platform with Industry-Grade Integrated Safety Functionality, Streamlining User Chemical Development Processes
Published on 03/11/2026 at 22:55, 1 hour 5 minutes ago Pathfinder Ventures Announces Closing of Parksville Refinancing and Extension of Private Placement
Published on 03/11/2026 at 19:00, 5 hours ago Worksport Announces Fourth Quarter and Full Year 2025 Earnings Date; Updated Financial Guidance and Path to Cash-Flow Positivity to Be Discussed
Published on 03/11/2026 at 21:30, 2 hours 30 minutes ago KPS CAPITAL PARTNERS TO ACQUIRE A CONTROLLING INTEREST IN JENNMAR
Published on 03/11/2026 at 18:19, 5 hours 40 minutes ago Fuller, Smith & Turner PLC: TR-1: Standard form for notification of major holdings
Published on 03/11/2026 at 18:11, 5 hours 48 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/11/2026 at 18:05, 5 hours 55 minutes ago Ridgewood Infrastructure Announces Sale of APP
Published on 03/11/2026 at 20:05, 3 hours 55 minutes ago CDA - Compte rendu de l'AG et du Conseil d'administration
Published on 03/11/2026 at 18:30, 5 hours 30 minutes ago Filing of the 2025 TF1 Universal Registration Document
Published on 03/11/2026 at 18:30, 5 hours 30 minutes ago Mise à disposition du Document d’Enregistrement Universel 2025 de TF1
